Measles deaths falling despite some objections to vaccines

A new study shows the number of deaths caused by measles has fallen by 79 percent worldwide since 2000, The New York Times reports.

Though the report provided encouraging statistics, 350 children still die from the disease every day.

“Without this commitment, children will continue to die from a disease that is easy and cheap to prevent,” said Robin Nandy, Unicef’s head of immunization.

Though measles don’t affect U.S. children in large numbers, it does affect those in countries such as Egypt, Ethiopia and Germany.

To read more about the disease and worldwide efforts to contain it, follow the link below.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.